A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
Status:
Completed
Trial end date:
2021-02-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of vedolizumab intravenous (IV) and
placebo in terms of the percentage of participants with chronic or recurrent pouchitis
achieving clinically relevant remission.